Management of Midostaurin-CYP3A4 Drug-Drug Interactions in Patients With Acute Myeloid Leukemia.

Management of Midostaurin-CYP3A4 Drug-Drug Interactions in Patients With Acute Myeloid Leukemia. Oncology (Williston Park). 2019 Jul 16;33(7): Authors: Schlafer D PMID: 31365750 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31365750?dopt=Abstract

Source: Oncology (Williston Park, N.Y.) - July 15, 2019 Category: Cancer & Oncology Authors: Schlafer D Tags: Oncology (Williston Park) Source Type: research

More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer & Oncology | Leukemia